EUVIMEDEUVIMED entdecken
Open Access

Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers

Tugce Duran, Sarah A Gaussoin, Lauren A Latham, Melissa M Rundle, Mark A Espeland, Benjamin J Williams, Timothy M Hughes, Suzanne Craft, Bonnie C Sachs, James R Bateman, Samuel N Lockhart

Journal of Alzheimer's Disease · 2024

DOI: 10.3233/jad-231435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Tugce Duran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine-Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroimaging, Telemedicine, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The preclinical Alzheimer’s cognitive composite (PACC) was developed for in-person administration to capture subtle cognitive decline. At the outset of the COVID-19 pandemic, cognitive testing was increasingly performed remotely by telephone or video administration. It is desirable to have a harmonized composite measurement derived from both in-person and remote assessments for identifying cognitive changes and to examine its relationship with common neuroimaging biomarkers.

Objective

We defined a telehealth compatible PACC (tPACC) and examined its relationship with neuroimaging biomarkers related to neurodegeneration, brain function and perfusion, white matter integrity, and amyloid-β.

Methods

We examined 648 participants’ neuroimaging and in-person and remote cognitive testing data from the Wake Forest Alzheimer’s Disease Research Center’s Clinical Core cohort (observational study) to calculate a modified PACC (PACC5-RAVLT) score and tPACC scores (in-person and remote). We performed Spearman/intraclass correlation coefficient (ICC) analyses for reliability of tPACC scores and linear regression models to evaluate associations between tPACC and neuroimaging. Bland-Altman plots for agreement were constructed across cognitively normal and impaired (mild cognitive impairment and dementia) participants.

Results

There was a significant positive relationship between tPACCin - person and PACC5-RAVLT (Overall group: r2 = 0.94, N = 648), and tPACCin - person and tPACCremote (validation subgroup: ICC = 0.82, n = 53). Overall, tPACC showed significant associations with brain thickness/volume, gray matter perfusion, white matter free water, and amyloid-β deposition.

Conclusions

There is a good agreement between tPACCand PACC5-RAVLTfor cognitively normal and impaired individuals. The tPACC is associated with common neuroimaging markers of Alzheimer’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroimagingTelemedicineCognitive DysfunctionBiomarkersNeuropsychological TestsHumansFemaleMaleAgedReproducibility of ResultsCOVID-19BrainAged, 80 and overMiddle AgedAmyloid beta-PeptidesMagnetic Resonance Imaging

Stichwörter der Autor:innen

Alzheimer’s diseaseMRIPETamyloid-betacognitive compositecognitive declinereliabilitytelehealth testing

Substanzen

BiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Internal Medicine-Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Förderung

  • NIA NIH HHS

Zitieren

APA

Duran, T., Gaussoin, S. A., Latham, L. A., Rundle, M. M., Espeland, M. A., Williams, B. J., Hughes, T. M., Craft, S., Sachs, B. C., Bateman, J. R., & Lockhart, S. N. (2024). Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-231435

Vancouver

Duran T, Gaussoin SA, Latham LA, Rundle MM, Espeland MA, Williams BJ, et al. Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-231435

BibTeX
@article{Duran2024,
  author = {Duran, Tugce and Gaussoin, Sarah A and Latham, Lauren A and Rundle, Melissa M and Espeland, Mark A and Williams, Benjamin J and Hughes, Timothy M and Craft, Suzanne and Sachs, Bonnie C and Bateman, James R and Lockhart, Samuel N},
  title = {Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  doi = {10.3233/jad-231435}
}
Kostenlos starten →